Cord Blood News Volume 13.03 | Jan 27 2021

    0
    136







    2021-01-28 | CBN 12.03


    Cord Blood News by STEMCELL Technologies
    Vol. 12.03 – 28 January, 2021
    TOP STORY

    Sandwich-Type Near-Infrared Conjugated Polymer Nanoparticles for Revealing the Fate of Transplanted Human Umbilical Cord Mesenchymal Stem Cells

    A novel strategy of sandwich-type encapsulation of the conjugated polymer interlayer in the crystalline SiO2 core + shell was developed, which worked well to avoid the aggregation-induced fluorescence quenching problem by homogeneously dispersing PFTBT and suppressing intermolecular π–π stacking.
    [ACS Applied Materials & interfaces]

    Full Article

    Getting enough cord blood HSCs for transplantation isn't easy. But she's paving the way. Watch Suzan Imren's webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Human Mesenchymal Stem Cell Therapy Promotes Retinal Ganglion Cell Survival and Target Reconnection after Optic Nerve Crush in Adult Rats

    Scientists investigated the efficacy of human umbilical Wharton’s jelly-derived MSCs and their extracellular vesicles in a rat model of optic nerve crush.
    [Stem Cell Research & Therapy]

    Full Article

    Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomal miR-146a-5p Reduces Microglial-Mediated Neuroinflammation via Suppression of the IRAK1/TRAF6 Signaling Pathway after Ischemic Stroke

    The authors found that injected human umbilcal cord-derived exosomes were able to access the site of ischemic damage and could be internalized by cells both in vivo and in vitro.
    [Aging-Us]

    Full Article

    Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations

    In order to understand the intrapopulation heterogeneity, various fractions of human amniotic fluid stem cells were isolated using the Celector® profile and live imaging feature. The gene expression profile of each fraction was analyzed using whole-transcriptome sequencing.
    [Cells]

    Abstract

    Human Amnion-Derived Mesenchymal Stem Cells Attenuate Xenogeneic Graft-versus-Host Disease by Preventing T Cell Activation and Proliferation

    Investigators assessed the immunosuppressive effects of human amnion-derived MSC in a xenogeneic graft-versus host disease NOD/Shi-scid IL2rγnull mouse model using human peripheral blood mononuclear cells.
    [Scientific Reports]

    Full Article

    Potential Surrogate Quantitative Immunomodulatory Potency Assay for Monitoring Human Umbilical Cord‐Derived Mesenchymal Stem Cells Production

    The immunomodulatory potency of human umbilical cord‐derived mesenchymal stem cells was demonstrated in the in vivo middle cerebral artery occlusion‐induced brain injury rat model and in vitro THP‐1‐derived macrophages model.
    [Cell Biology International]

    Abstract

    Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton’s Jelly

    Researchers characterized the protein secretome of adipose, bone marrow, placenta, and Wharton’s jelly-derived human MSCs by using conditioned media and analyzing the secretome by mass spectrometry and follow-up bioinformatics.
    [International Journal of Molecular Sciences]

    Full Article
    Learn more about cGMP-manufactured StemSpan™-ACF Without Phenol Red for culturing hematopoietic cell therapy products
    REVIEWS

    Mesenchymal Stromal Cells for Systemic Sclerosis Treatment

    MSCs demonstrate in vitro and in vivo pro-angiogenic, immuno-suppressive, and anti-fibrotic properties and appear as a promising stem cell therapy type, that may target the key pathological features of systemic sclerosis disease.
    [Autoimmunity Reviews]

    Abstract

    Human Umbilical Cord: Information Mine in Sex-Specific Medicine

    The authors review current findings regarding sex differences observed in the umbilical cord, a widely used source of research samples, both in the blood and in the circulating cells, as well as in the different cellular models obtainable from it.
    [Life]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Sorrento Announces Positive Preliminary Results of Phase Ib Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

    Sorrento Therapeutics, Inc. announced preliminary results from its Phase Ib study of human allogeneic adipose-derived mesenchymal stem cells for patients suffering from COVID-19-induced acute respiratory distress or acute respiratory distress syndrome.
    [Sorrento Therapeutics, Inc.]

    Press Release
    FEATURED EVENT

    The European Society for Blood and Marrow Transplantation

    March 14 – 17, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Training Fellowships – Glycosciences

    Blood Research Institute – Milwaukee, Wisconsin, United States

    Postdoctoral Associate – Epigenetic Mechanisms Governing Hematopoietic Stem Cell Lineage Commitment

    The Jackson Laboratory – Bar Harbor, Maine, United States

    Research Associate – Pediatric Myeloid Tumors

    St. Jude Children’s Hospital – Memphis, Tennessee, United States

    Research Assistant – Cord Blood and Stem Cell Products

    University of Colorado – Aurora, Colorado, United States

    Postdoctoral Researcher – Mitochondria and Hematopoietic Stem Cell Biology

    Columbia University Medical Center – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cord Blood News Twitter